Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Risk of Venous Thrombosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT04309240
What this trial is testing

Rivaroxaban for Thromboprophylaxis in High-risk Cancer Patients With Totally Implantable Access Ports

Who this might be right for
RivaroxabanThromboprophylaxisCancer
LiuZhou People's Hospital 204
Not applicableEnded earlyNCT05819125
What this trial is testing

Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With Enoxaparin

Who this might be right for
Venous Thromboembolism
Sanofi 21,000
Large-scale testing (Phase 3)Study completedNCT03285438
What this trial is testing

REduced Dose Versus Full-dose of Direct Oral Anticoagulant After uNprOvoked Venous thromboEmbolism.

Who this might be right for
Venous Thromboembolism
University Hospital, Brest 2,774
Not applicableUnknownNCT03909399
What this trial is testing

Prevention and Prophylaxis of Cancer Associated Thrombosis in High Risk Oncology Patients

Who this might be right for
Deep Vein ThrombosisPulmonary EmbolismVena Cava Thrombosis+1 more
Hellenic Society of Medical Oncology 500
Large-scale testing (Phase 3)WithdrawnNCT00912483
What this trial is testing

Efficacy of Sodium Heparin in Prophylaxis of Venous Thromboembolism in Surgical Patients

Who this might be right for
Venous Thromboembolism
Azidus Brasil
Not applicableEnded earlyNCT03038750
What this trial is testing

Molecular Investigation of Genetic Factors in CArDiovascular Diseases Using an BIOresource of Healthy Volunteers

Who this might be right for
Cardiovascular Diseases
Cambridge University Hospitals NHS Foundation Trust 74
Large-scale testing (Phase 3)Study completedNCT00056550
What this trial is testing

Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations.

Who this might be right for
Antithrombin Deficiency, Congenital
rEVO Biologics 14
Not applicableWithdrawnNCT01446510
What this trial is testing

Systematic Review and Meta-Analysis of Venous Thromboembolism (VTE) Risk Assessment in Hospitalized Medical Patients

Who this might be right for
Venous Thromboembolism
Intermountain Health Care, Inc.
Not applicableStudy completedNCT05890924
What this trial is testing

Intimate Partner Violence as a Risk Factor for Venous Thromboembolism in Women

Who this might be right for
Venous Thrombosis
Centre Hospitalier Universitaire de Nīmes 997
Not applicableLooking for participantsNCT07288632
What this trial is testing

Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer

Who this might be right for
Venous Thromboembolism (VTE)NSCLC (Advanced Non-small Cell Lung Cancer)
University Of Perugia 500
Not applicableUnknownNCT05515549
What this trial is testing

Value of D-dimer Combined With Other Thrombus Molecular Markers in Risk Assessment of VTE in Hospitalized Patients

Who this might be right for
Venous Thromboembolic Disease
Qianfoshan Hospital 300
Post-approval studies (Phase 4)Study completedNCT02559856
What this trial is testing

Comparison of Bleeding Risk Between Rivaroxaban and Apixaban: The Pilot Study

Who this might be right for
Venous Thromboembolism
Ottawa Hospital Research Institute 71
Not applicableStudy completedNCT03309293
What this trial is testing

Construction and External Validation of a Predictive Clinico-biological Score of the Risk of Venous Thrombosis in Women Under Combined Oral Contraceptives

Who this might be right for
Venous Thromboembolism
Assistance Publique Hopitaux De Marseille 1,454
Not applicableUnknownNCT05150314
What this trial is testing

Comparative Study of the Hemorrhagic Risk in Patients Over 75 Years of Age Taking Enoxaparin

Who this might be right for
Venous Thromboembolic Disease
University Hospital, Strasbourg, France 2,000
Not applicableUnknownNCT05498142
What this trial is testing

Predicting the Risk of Venous Thromboembolism in Critically Ill Patients

Who this might be right for
Venous ThromboembolismCritical Illness
University Medical Center Groningen 7,600
Testing effectiveness (Phase 2)Study completedNCT01524653
What this trial is testing

Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE)

Who this might be right for
Venous ThromboembolismDeep Vein ThrombosisNeoplasms
University of Vermont 38
Not applicableEnded earlyNCT05819112
What this trial is testing

A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical Illness

Who this might be right for
Venous Thromboembolism
Sanofi 14,799
Not applicableLooking for participantsNCT06731244
What this trial is testing

Shared Decision-making Process for Unprovoked vEnous THromboEmbolism Management. (ETHER )

Who this might be right for
Venous Thromboembolism
University Hospital, Brest 2,400
Large-scale testing (Phase 3)Study completedNCT04670432
What this trial is testing

Resolution Enhancement by a Supplemental Obstruction Lessening Venoactive Drug for Eight Weeks in Deep Vein Thrombosis

Who this might be right for
Deep Vein Thrombosis
Maastricht University Medical Center 44
Not applicableStudy completedNCT05439187
What this trial is testing

Risk Factors of Venous Thromboembolism After Incisional Ventral Hernia Repair.

Who this might be right for
Incisional HerniaVenous Thromboembolism
Pirogov Russian National Research Medical University 240
Next Page